NMRA vs XOM · $283.5M cap vs P/E 24, rev $332.24B
Neumora Therapeutics, Inc. (NMRA) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
NMRA does not have a complete income-statement cache yet.
Latest reported XOM revenue for 2025-12-31 was $332.24B. Net income was $28.84B. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
NMRA currently screens at market cap $283.5M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the NMRA and XOM stock pages for the full models.
Not investment advice.